SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-056421
Filing Date
2022-11-10
Accepted
2022-11-10 17:05:47
Documents
2
Period of Report
2022-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1621
2 POA DOCUMENT poa.txt EX-24 3845
  Complete submission text file 0001209191-22-056421.txt   6975
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERESTHERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
von Moltke Lisa (Reporting) CIK: 0001808592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36279 | Film No.: 221378396